Listed times are in Central European Summer Time (CEST)

REGISTRATION

WELCOME LUNCH

CONFERENCE WELCOME

Session 1

Session Chair: Joan Seoane

Myriam Chalabi NKI Amsterdam, Amsterdam, Netherlands

Neoadjuvant immunotherapy in pMMR and dMMR colorectal cancers

Q&A 14:00 - 14:10

Marcela Maus Harvard, Cambridge, USA

Driving new CAR T cells

Q&A 14:30 - 14:40

The EMBO Keynote Lecture

Ido Amit Weizmann Institute of Science, Rehovot, Israel

The power of ONE: Immunology in the age of spatial and single cell genomics

Q&A 15:00 - 15:10

COFFEE BREAK & SOLO TRAVELLERS' MEET-UP

SATELLITE SYMPOSIUM - ELITE SPONSOR

KEYNOTE LECTURE

Antoni Ribas UCLA, Los Angeles, USA

Multicellular interactions mediating response and resistance to cancer immunotherapy

Q&A 16:40 - 16:55

Omer Dushek Sir William Dunn School of Pathology, University of Oxford, Oxford, UK

Reducing off-target cross-reactivity without impacting on-target sensitivity for safe and effective TCR-T cell therapies

Q&A 17:15 - 17:25

5 Proffered Papers

COFFEE BREAK

Speed Networking

WELCOME BUFFET & DRINKS

POSTER DISCUSSION SESSION 1

Listed times are in Central European Summer Time (CEST)

Session 2

Session Chair: Yardena Samuels

5 Proffered Papers

Johanna Joyce University of Lausanne, Lausanne, Switzerland

Exploring and therapeutically exploiting the tumour microenvironment

Q&A 09:50 - 10:00

Joan Seoane VHIO, Barcelona, Spain

Impact of the tumor microenvironment on immunotherapies targeting brain cancer

Q&A 10:20 - 10:30

Maria Casanova-Acebes CNIO, Madrid, Spain

Circadian immunity: can we exploit it therapeutically?

Q&A 10:50 - 11:00

COFFEE BREAK

SATELLITE SYMPOSIUM - ELITE SPONSOR

5 Proffered Papers

LUNCH

Session 3

Session Chair: Sonia Guedan

KEYNOTE LECTURE

Alberto Mantovani Queen Mary University of London, London, UK

The yin yang of tumour-associated macrophages

Q&A 14:30 - 14:45

Filipe Pereira Lund University, Lund, Sweden

A cancer immunotherapy modality based on dendritic cell reprogramming in vivo

Q&A 15:05 - 15:15

Yardena Samuels Weizmann Institute of Science, Rehovot, Israel

Revisiting the neoantigen approach to cancer immunotherapy

Q&A 15:35 - 15:45

COFFEE BREAK

Panel Discussion: Mechanisms of acquired resistance to immunotherapies

Joan Seoane (VHIO, Barcelona, Spain), Sonia Guedan (Clinic Barcelona, Barcelona, Spain), Ignacio Melero (Cima Universidad de Navarra, Pamplona, Spain), Yardena Samuels (Weizmann Institute, Rehovot, Israel), Josep Tabernero (VHIO, Barcelona, Spain)

5 Proffered Papers

POSTER DISCUSSION SESSION 2

CONFERENCE DINNER (optional ticketed event)

Listed times are in Central European Time (CEST)

Session 4

Session Chair: Ignacio Melero

5 Proffered Papers

Sonia Guedan IDIBAPS, Barcelona, Spain

Next generation CAR-T cells for cancer treatment

Q&A 09:50 - 10:00

Christopher Klebanoff Memorial Sloan Kettering Institute, New York, USA

Therapeutic targeting of human cancers using CD4+ T cells

Q&A 10:20 - 10:30

Rony Dahan Weizmann Institute of Science, Rehovot, Israel

Antibody-based cancer immunotherapies

Q&A 10:50 - 11:00

COFFEE BREAK

KEYNOTE LECTURE

Tak Mak Princess Margaret Cancer Centre, Toronto, Canada

Metabolic and neural regulation of immunity and cancer

Q&A 12:00 - 12:15

SUMMARY AND AWARDS PRESENTATION

DEPART